- Home
- DCTH vs OSUR Comparison
DCTH vs OSUR Comparison
Compare DCTH & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- OSUR
- Stock Information
- Founded
- DCTH 1988
- OSUR 2000
- Country
- DCTH United States
- OSUR United States
- Employees
- DCTH N/A
- OSUR N/A
- Industry
- DCTH Medical/Dental Instruments
- OSUR Medical/Dental Instruments
- Sector
- DCTH Health Care
- OSUR Health Care
- Exchange
- DCTH Nasdaq
- OSUR Nasdaq
- Market Cap
- DCTH 352.0M
- OSUR 289.4M
- IPO Year
- DCTH N/A
- OSUR 1986
- Fundamental
- Price
- DCTH $11.95
- OSUR $3.64
- Analyst Decision
- DCTH Strong Buy
- OSUR Hold
- Analyst Count
- DCTH 4
- OSUR 2
- Target Price
- DCTH $21.50
- OSUR $5.50
- AVG Volume (30 Days)
- DCTH 345.3K
- OSUR 1.0M
- Earning Date
- DCTH 11-08-2024
- OSUR 11-06-2024
- Dividend Yield
- DCTH N/A
- OSUR N/A
- EPS Growth
- DCTH N/A
- OSUR N/A
- EPS
- DCTH N/A
- OSUR 0.15
- Revenue
- DCTH $22,644,000.00
- OSUR $224,263,000.00
- Revenue This Year
- DCTH $1,605.13
- OSUR N/A
- Revenue Next Year
- DCTH $111.67
- OSUR N/A
- P/E Ratio
- DCTH N/A
- OSUR $24.13
- Revenue Growth
- DCTH 945.91
- OSUR N/A
- 52 Week Low
- DCTH $3.70
- OSUR $3.58
- 52 Week High
- DCTH $13.30
- OSUR $8.45
- Technical
- Relative Strength Index (RSI)
- DCTH 51.68
- OSUR 37.25
- Support Level
- DCTH $10.75
- OSUR $3.76
- Resistance Level
- DCTH $11.59
- OSUR $3.70
- Average True Range (ATR)
- DCTH 0.70
- OSUR 0.17
- MACD
- DCTH -0.11
- OSUR -0.03
- Stochastic Oscillator
- DCTH 24.56
- OSUR 0.83
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.